TECHBIO-TECHNE Corp

Nasdaq bio-techne.com


$ 82.84 $ -0.66 (-0.79 %)    

Thursday, 16-May-2024 15:59:56 EDT
QQQ $ 451.64 $ -1.83 (-0.4 %)
DIA $ 399.14 $ -0.14 (-0.04 %)
SPY $ 528.49 $ -1.29 (-0.24 %)
TLT $ 92.06 $ -0.04 (-0.04 %)
GLD $ 220.06 $ -0.83 (-0.38 %)
$ 82.84
$ 82.25
$ 0.00 x 0
$ 82.91 x 181
$ 82.25 - $ 83.81
$ 51.61 - $ 89.50
1,149,196
na
13.4B
$ 1.05
$ 66.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-Q
3 11-07-2023 09-30-2023 10-Q
4 08-23-2023 06-30-2023 10-K
5 05-08-2023 03-31-2023 10-Q
6 02-07-2023 12-31-2022 10-Q
7 11-07-2022 09-30-2022 10-Q
8 08-24-2022 06-30-2022 10-K
9 05-09-2022 03-31-2022 10-Q
10 02-07-2022 12-31-2021 10-Q
11 11-08-2021 09-30-2021 10-Q
12 08-25-2021 06-30-2021 10-K
13 05-07-2021 03-31-2021 10-Q
14 02-08-2021 12-31-2020 10-Q
15 11-09-2020 09-30-2020 10-Q
16 08-26-2020 06-30-2020 10-K
17 05-11-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-Q
19 11-06-2019 09-30-2019 10-Q
20 08-28-2019 06-30-2019 10-K
21 05-07-2019 03-31-2019 10-Q
22 02-07-2019 12-31-2018 10-Q
23 11-07-2018 09-30-2018 10-Q
24 08-27-2018 06-30-2018 10-K
25 05-09-2018 03-31-2018 10-Q
26 02-08-2018 12-31-2017 10-Q
27 11-09-2017 09-30-2017 10-Q
28 09-07-2017 06-30-2017 10-K
29 05-10-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-Q
31 11-09-2016 09-30-2016 10-Q
32 08-29-2016 06-30-2016 10-K
33 05-10-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-Q
35 11-09-2015 09-30-2015 10-Q
36 08-31-2015 06-30-2015 10-K
37 05-11-2015 03-31-2015 10-Q
38 02-09-2015 12-31-2014 10-Q
39 11-10-2014 09-30-2014 10-Q
40 08-29-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 which-large-cap-stocks-are-winning-this-earnings-season-15-stocks-to-watch-april-28-may-4-2024

Last week's top performers included Carvana, Pinterest, Moderna and JD.Com.

 benchmark-reiterates-buy-on-bio-techne-maintains-95-price-target

Benchmark analyst Robert Wasserman reiterates Bio-Techne (NASDAQ:TECH) with a Buy and maintains $95 price target.

 baird-maintains-outperform-on-bio-techne-raises-price-target-to-81

Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $73 to...

 bio-techne-q3-adj-048-beats-045-estimate-sales-30343m-beat-29219m-estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.45 by 6...

Core News & Articles

Under this agreement, Thermo Fisher, through the European arm of its Fisher Scientific Channel, will distribute Bio-Techne'...

 bio-techne-and-novomol-dx-have-announced-the-development-of-bio-marker-pathfinder-an-ocular-biomarker-kit-as-a-point-of-care-application

The BMP kit runs on Bio-Techne's Ella™, a benchtop automated immunoassay platform leveraging Bio-Techne's R&D Syste...

 deutsche-bank-maintains-buy-on-bio-techne-lowers-price-target-to-82

Deutsche Bank analyst Justin Bowers maintains Bio-Techne (NASDAQ:TECH) with a Buy and lowers the price target from $85 to $82.

 bio-techne-surpasses-10k-peer-reviewed-publications-citing-rnascope-technology

Bio-Techne Corporation (NASDAQ:TECH) today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Bio...

 bio-techne-and-nikon-instruments-inc-announce-partnership-to-expand-access-to-innovative-spatial-biology-services

Bio-Techne Corporation (NASDAQ:TECH) is pleased to announce that Lunaphore, part of Bio-Techne's Spatial Biology Division, ...

Core News & Articles

By the end of today, February 26, 2024, Bio-Techne (NASDAQ:TECH) is set to deliver a dividend payout of $0.08 per share, equati...

 stephens--co-maintains-overweight-on-bio-techne-lowers-price-target-to-87

Stephens & Co. analyst Jacob Johnson maintains Bio-Techne (NASDAQ:TECH) with a Overweight and lowers the price target fr...

 rbc-capital-maintains-sector-perform-on-bio-techne-lowers-price-target-to-75

RBC Capital analyst Conor McNamara maintains Bio-Techne (NASDAQ:TECH) with a Sector Perform and lowers the price target from...

 stifel-downgrades-bio-techne-to-hold-announces-65-price-target

Stifel analyst Daniel Arias downgrades Bio-Techne (NASDAQ:TECH) from Buy to Hold and announces $65 price target.

 bio-techne-q2-adj-eps-040-misses-041-estimate-sales-27260m-miss-27753m-estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.41 by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION